Mutated alpha-1 antitrypsin (ApcinteX)

N/A

Report date: 2025/02/12 20:00:40

Base Information

Drug NameMutated alpha-1 antitrypsin (ApcinteX)
Drug Alias Name突变的α-1抗胰蛋白酶-ApcinteX LtdSerpinPC
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionVitamin K-dependent protein C inhibitors
TargetsVitamin K-dependent protein C
Therapy Area/IndicationsHemophilia BHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumArmeniaCanada +[17] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesApcintex Ltd
China Registration ClassN/A

Develop Information

Active CompaniesApcintex LtdCentessa Pharmaceuticals Plc
Inactive CompaniesN/A
Active IndicationsHemophilia BHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A